{"id":1624,"date":"2023-06-25T17:28:42","date_gmt":"2023-06-25T17:28:42","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/aluminium-hydroxide\/"},"modified":"2023-06-25T19:59:12","modified_gmt":"2023-06-25T19:59:12","slug":"aluminium-hydroxide","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/aluminium-hydroxide\/","title":{"rendered":"Aluminium hydroxide"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/kidneydiseaseclinic.net\/renaldrugs\/img\/Aluminium hydroxide.JPG\"><\/p>\n<h1>Aluminium hydroxide<\/h1>\n<h3>  CLINICAL USE<\/h3>\n<li>Phosphate binding agent<\/li>\n<li>Antacid<br \/>\n<h3> DOSE IN NORMAL RENAL FUNCTION<\/h3>\n<\/li>\n<li>Phosphate binder: 4\u201320 capsules daily individed doses<\/li>\n<li>Antacid: 1 capsule 4 times daily and atbedtime<br \/>\n<h3>  PHARMACOKINETICS<\/h3>\n<\/li>\n<li> Molecular weight &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :<br \/>\n78<\/li>\n<li>  %Protein binding  &nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :<br \/>\n70\u201390<\/li>\n<li>  %Excreted unchanged in urine &nbsp; &nbsp; :<br \/>\nNo data<\/li>\n<li> Volume of distribution (L\/kg) &nbsp; &nbsp; &nbsp; :<br \/>\nNo data<\/li>\n<li>half-life \u2013 normal\/ESRD (hrs)&nbsp; &nbsp; &nbsp; :<br \/>\nNo data<\/p>\n<h3>  DOSE IN RENAL IMPAIRMENT<\/h3>\n<h4>GFR (mL\/MIN)<\/h4>\n<\/li>\n<li> 20 to 50  &nbsp; &nbsp; : Dose as in normal renal function<\/li>\n<li> 10 to 20  &nbsp; &nbsp; : Dose as in normal renal function<\/li>\n<li> &lt;10 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :<br \/>\nDose as in normal renal function<\/p>\n<h3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES<\/h3>\n<\/li>\n<li> CAPD  &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;:<br \/>\nUnknown dialysability. Dose as in<br \/>\nnormal renal function<\/li>\n<li> HD &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :<br \/>\nUnknown dialysability. Dose as in<br \/>\nnormal renal function<\/li>\n<li>HDF\/high flux  &nbsp; :<br \/>\nUnknown dialysability. Dose as in<br \/>\nnormal renal function<\/li>\n<li>CAV\/VVHD  &nbsp; &nbsp; &nbsp;:<br \/>\nUnknown dialysability. Dose as in<br \/>\nnormal renal function<\/p>\n<h3> IMPORTANT DRUG INTERACTIONS<\/h3>\n<p>Potentially hazardous interactions with other drugs<br \/>\nNone known<\/p>\n<h3> ADMINISTRATION<\/h3>\n<h4> Reconstition<\/h4>\n<p>\u2013<\/p>\n<h4>  Route<\/h4>\n<p>Oral<\/p>\n<h4>  Rate of Administration<\/h4>\n<p>\u2013<\/p>\n<h4>Comments<\/h4>\n<p>\u2013<\/p>\n<h4>  OTHER INFORMATION<\/h4>\n<\/li>\n<li>K\/DOQI guidelines caution that CKD 5patients on chronic therapy may develop<br \/>\naluminium toxicity; therefore best avoided<br \/>\nin all but short-term therapy (calcium<br \/>\ncarbonate, calcium acetate, lanthanum or<br \/>\nsevelamer are used in chronic therapy)<\/li>\n<li>Take\/administer with or immediatelybefore meals<\/li>\n<li>In patients undergoing chronic therapywith aluminium hydroxide, serum<br \/>\naluminium levels should be monitored<\/li>\n","protected":false},"excerpt":{"rendered":"<p>Aluminium hydroxide CLINICAL USE Phosphate binding agent Antacid DOSE IN<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-1624","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=1624"}],"version-history":[{"count":1,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1624\/revisions"}],"predecessor-version":[{"id":2941,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1624\/revisions\/2941"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=1624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=1624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=1624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}